Quetiapine Fumarate Tablet
Product Images NDC 50090-6812

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50090-6812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (A644051f 21f4 4c76 9ed2 E96417d77df9 01)

Molecular Structure (A644051f 21f4 4c76 9ed2 E96417d77df9 01)
Chemical structure of quetiapine fumarate, showing the quetiapine moiety with a thiazepine ring and piperazine ring, and the fumarate anion. The structure includes the molecular features of both components.*
FDA Label Image

Figure 1 (A644051f 21f4 4c76 9ed2 E96417d77df9 02)

Figure 1 (A644051f 21f4 4c76 9ed2 E96417d77df9 02)
A Kaplan-Meier survival curve showing the proportion of patients with relapse (%) over time in weeks up to 100 weeks. The graph compares two groups: one treated with Quetiapine (QTP) plus lithium/valproate (LI/VAL) and the other with placebo (PLA) plus lithium/valproate. The QTP+LI/VAL group shows a lower proportion of patients with relapse over time compared to PLA+LI/VAL.*
FDA Label Image

Figure 2 (A644051f 21f4 4c76 9ed2 E96417d77df9 03)

Figure 2 (A644051f 21f4 4c76 9ed2 E96417d77df9 03)
A line chart depicting the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. Two groups are shown: QTP+LI/VAL with a dashed line, and PLA+LI/VAL with a solid line, illustrating different relapse rates across the study period.*
FDA Label Image

Image (35b3883e Bd69 43d5 8f5a 254dd92cd528 1584 1)

Image (35b3883e Bd69 43d5 8f5a 254dd92cd528 1584 1)
Quetiapine fumarate 100 mg oral tablet by A-S Medication Solutions. The image shows a white round tablet labeled with an imprint of "6812" divided across the tablet surface, indicating its strength and identification. The tablet is uncoated and flat, designed for oral administration.*
FDA Label Image

Image (9fb56acd 2611 4c7d B63f 1de0c57383ea 1628 1)

Image (9fb56acd 2611 4c7d B63f 1de0c57383ea 1628 1)
Quetiapine fumarate 100 mg oral tablets packaged in a blister card containing 10 tablets. The package shows the brand name Quetiapine fumarate, strength 100 mg, and is labeled by A-S Medication Solutions. The blister card is partially visible with tablets arranged in two columns.*
FDA Label Image

Label Image (Lbl500906812)

Label Image (Lbl500906812)
Quetiapine fumarate 100 mg oral tablets, supplied by A-S Medication Solutions. The label shows a bottle containing 30 tablets with storage instructions to keep at 77 degrees Fahrenheit. The label includes dosage information referring to the package insert and identifies the product NDC as 50090-6812-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.